Group 1 - The company will start paying interest on its convertible bonds issued on March 4, 2024, from March 4, 2025, to March 3, 2026 [2] - The total issuance scale of the convertible bonds is RMB 1,797.43 million, with 17,974,320 bonds issued at a face value of RMB 100 each [5] - The bond has a six-year term, maturing on March 3, 2030, with an annual interest rate that increases from 0.30% in the first year to 2.00% in the sixth year [2][10] Group 2 - The interest payment will be made annually, with the first payment scheduled for March 4, 2026, and the interest amount for the second year set at RMB 0.50 per bond [15][21] - The bondholders must be registered with the China Securities Depository and Clearing Corporation Limited Shanghai Branch by March 3, 2026, to receive the interest [17][21] - The initial conversion price for the bonds is set at RMB 39.85 per share, which has been adjusted to RMB 31.84 due to corporate actions [10] Group 3 - The company has a credit rating of AA, and the bonds also carry the same rating with a stable outlook [11] - The bonds will be listed on the Shanghai Stock Exchange on March 27, 2024 [14] - The company has appointed China Securities Depository and Clearing Corporation Limited Shanghai Branch for bond custody and interest payment services [18]
益丰大药房连锁股份有限公司关于可转换公司债券付息的公告